Parallel A1

Title: Lung Cancer & Biomarker-Driven Treatment in Oncology

 

Day: 1

Date: 13 December 2024

Time: 2:00 PM-4:00 PM

Venue: Hall-1

Session: Parallel A1

 

Chairperson:

Prof. Dr. Md. Mofazzel Hossain, Prof. Dr. Md. Abul Ahsan (Didar), Dr. Asif Mujtaba Mahmud

 

Moderator:

          Dr. (Lt. Col) Nazat Sultana

Speakers:

Sl Topic Name  Country Duration
01 Concurrent Chemoradiotherapy & Consolidation Approach in NSCLC Dr.Muthukkumaran Thiagarajan  Malaysia 20 Min
02 Role of SBRT in central and ultra-central early lung cancer Dr. Jamal Khader Jordan 20 Min
03

Small Cell Lung Cancer in 2024: Challenges and New Opportunities

Dr. Guru Sharan Sah Nepal 15 Min


Biomarker-Driven Treatment in Oncology
 

Sl Topic Name Country Duration
01 Current Scenario of Biomarker-Driven Practice in Bangladesh  Dr. Md. Rafiqul Islam Bangladesh 10 Minutes
02

What is the scope of standard lab service for biomarker testing? How can ICDDRB contribute?

Dr. Md Mustafizur Rahman Bangladesh 10 Minutes




Panel of Expert Discussion: 

•What are the challenges—availability, cost, and reliability—and how can they be overcome?

 

Expert:

           Prof. Md. Mofazzel Hossain(Lt Col- Retd), Prof. Dr. Syed Md. Akram Hussain, Dr. Md Mustafizur Rahman

           Dr. Md. Rafiqul Islam

Global Expert: 

  Dr. Swrashat Sukumar, Prof. Dr. Kumar Prabhash, Dr. Muthukkumaran Thiagarajan, Dr. Jamal Khader

Moderator:

           Dr. Arman Reza Chowdhury